Related Experiment Videos

Phosphorylation of atrial natriuretic factor R1 receptor by serine/threonine protein kinases: evidences for receptor

L Larose1, J J Rondeau, H Ong

  • 1Department of Pharmacology, University of Montreal, Canada.

Insights

Atrial natriuretic factor receptor (ANF-R1) phosphorylation by protein kinase C inhibits guanylate cyclase activity. This may contribute to hypertension by altering ANF signaling pathways.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Endocrinology

Background:

  • Atrial natriuretic factor receptor (ANF-R1) plays a role in regulating blood pressure.
  • Protein kinases can modulate receptor function through phosphorylation.

Purpose of the Study:

  • To investigate the effect of protein kinase C (PKC) on ANF-R1 activity in bovine adrenal zona glomerulosa cells.
  • To explore the potential link between ANF-R1 phosphorylation and hypertension pathogenesis.

Main Methods:

  • Purification and in vitro phosphorylation of ANF-R1.
  • Treatment of bovine adrenal zona glomerulosa cells with TPA (phorbol ester) and calphostin C.
  • Measurement of ANF-stimulated cGMP accumulation and guanylate cyclase activity.
  • Assessment of 125I-ANF binding.
  • Analysis of 32P incorporation into ANF-R1.

Main Results:

  • ANF-R1 is phosphorylated by serine/threonine kinases, including PKC, independent of ANF binding.
  • TPA treatment inhibited ANF-stimulated cGMP accumulation and guanylate cyclase activity without altering ANF binding.
  • TPA-induced inhibition was abolished by a PKC inhibitor, calphostin C, and correlated with increased ANF-R1 phosphorylation.
  • Significant 32P incorporation into ANF-R1 was observed in TPA-treated cells.

Conclusions:

  • Protein kinase C phosphorylates ANF-R1 in zona glomerulosa cells, leading to blunted guanylate cyclase response to ANF.
  • This phosphorylation-mediated inhibition of ANF signaling may be implicated in the development of hypertension.

Related Concept Videos